Eurofarma Laboratórios S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was BRL 7,067.83 million compared to BRL 5,723.19 million a year ago. Net income was BRL 957.52 million compared to BRL 817.03 million a year ago.

Basic earnings per share from continuing operations was BRL 1.1151 compared to BRL 0.9546 a year ago. Diluted earnings per share from continuing operations was BRL 1.1151 compared to BRL 0.9546 a year ago.